Company Legal Name
Latest Valuation
Founded Year
Headquarter
Hone Health operates a specialized telehealth platform focused exclusively on men's testosterone therapy and hormone optimization. Founded in 2020 and headquartered in New York, the company provides comprehensive at-home testing, virtual consultations with licensed physicians, and direct-to-consumer prescription delivery services. Hone Health differentiates itself in the crowded telehealth market through its targeted approach to men's hormonal health, combining diagnostic testing with ongoing monitoring and personalized treatment plans. The company leverages a streamlined digital experience to address the growing demand for convenient, privacy-focused healthcare solutions in the men's wellness segment, positioning itself within the expanding hormone replacement therapy market.
Revenue & Revenue Growth Share
Revenue
Revenue Growth
Available in most regions; subject to local regulations.
Open to non-accredited investors with KYC/AML compliance. U.S. investors must meet SEC requirements.
$10 per token, enabling fractionalized access to Pre-IPO shares.
Mandatory identity (KYC) and proof of funds checks.
Variable, applied to investment amounts.
Charged on realized profits.
Tokens may be locked for 6–12 months; resale depends on secondary market liquidity.
Prices reflect past funding rounds, not guaranteed future value.
Biotech depends on regulatory approvals; fintech faces evolving digital asset rules.
Blockchain or custodian issues could delay transfers or verification.
Changing laws may affect tradability or taxation.





